New Journal for ImmunoTherapy of Cancer article: Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma bit.ly/4lcxHLC
@riyuesunnybao.bsky.social @pancpathologist.bsky.social
@zervanto.bsky.social @jasonlukemd.bsky.social
#JITC #cancer #MedSky
🔥 Great discussion at the in person meeting of the GLOBAL GUIDELINES FOR CYSTIC TUMORS OF THE PANCREAS
expected to be released 🔜 stay tuned!
@letswinpc.org #HPBSky
A huge majority of Americans (77%) oppose the cuts to medical research that the current administration has made.
(Source: Wash. Post/ABC/Ipsos poll)
A little late, but what a wonderful time supporting #PancreaticCancer research at @pancan.bsky.social purplestride in Pittsburgh. @news.upmc.com @upmc.com @upmchillmancc.bsky.social
27.04.2025 13:05 — 👍 4 🔁 0 💬 1 📌 0If you or someone you love has been diagnosed with #pancreaticcancer, you’re not alone — we’re here to help. 💜 Our educational packets include essential resources to help you navigate next steps. Access these materials digitally 🖥️ or have them mailed to you 📬 by visiting pcan.at/skpmuj.
10.04.2025 18:13 — 👍 2 🔁 1 💬 0 📌 0This is catastrophic for pancreatic cancer patients
26.03.2025 12:11 — 👍 145 🔁 78 💬 4 📌 6Truly unfortunate. But great image. Would love to evaluate by whole transcriptome to see differences between these neoplasms as opposed to conventional CRC have...
22.03.2025 14:01 — 👍 0 🔁 0 💬 0 📌 0Nice case! MSS or MSI?
22.03.2025 11:42 — 👍 0 🔁 0 💬 1 📌 0
In HER2-positive early #breastcancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival
Check out the full story 👇
www.curetoday.com/view/kadcyla...
Our incredible Team PanCAN runners are lacing up for the LA Marathon and Charity Half Marathon, and the United Airlines NYC Half Marathon today! 💜🏃♂️ They’ve spent months training and fundraising to make a difference for pancreatic cancer patients. Let’s show them some love in the comments!
16.03.2025 12:00 — 👍 4 🔁 1 💬 0 📌 0
Serous Cystadenoma HOP with Vascular Map
23.12.2024 22:39 — 👍 2 🔁 2 💬 0 📌 0
💥 A Stellar episode of our virtual meeting on pancreas topic.. this time IPMN 🍇 !!!
🚨 Integrating molecular testing to the evaluation of Pancreatic Cyst with the great @pancpathologist.bsky.social 🇺🇸 @upmc.bsky.social
Thank you, Aatur Singhi, for such a Christmas gift!!! 🎄
youtu.be/fF7HcPCqiwk
Benign Pancreatic Tumors
Read more here: ctisus.com/learning/fea...
More data on role of ATRX/DAXX loss for surgery in pancreas #NETs
👥116 PNETs in 🇯🇵
🧬11% DAXX & 7% ATRX loss 👉🏻intratumoral heterogeneity in 1/3
⬇️RFS with ATRX/DAXX loss
Should it be done routinely on all PNETs?
🔗 pubmed.ncbi.nlm.nih.gov/38909708/
#NETsSky #HPBSky #SurgSky #PancSky
PNET: CT Findings
ctisus.com/learning/fea...
Pancreatic Paraganglioma: CT Findings
ctisus.com/learning/fea...
Is the other ALT (alternative lengthening of telomeres) ready for use in pNETs..? I think so, especially for prognostication after resection. Chromogenic ISH (CISH) easier to implement than FISH. Excellent stuff from Chris Heaphy, Aatur Singhi et al.
www.sciencedirect.com/science/arti...
